0
Upcoming Allied Market Research
2023
Pharma Ophthalmic Market

Pharma Ophthalmic Market

by Product Type (Retinal Disorder Drugs, Allergic), by Application (Glaucoma, Dry Eye Syndrome, Retinal Diseases, Other Ophthalmic Indications) and by Distribution Channel (Hospital Pharmacy, Drugs Store  , Retail Pharmacist, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A12347
Pages: NA
Jul 2023 | 1511 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Pharma Ophthalmic Market

Request Now !

Ophthalmic drug is a pharmaceutical formulation, which is intended for the use of eye. Ophthalmic drugs are administered through eye cavity to treat bacterial infection of eye, eye injury, glaucoma, cataract, and dry eyes. Anti-angiogenic ophthalmic agents, anti-inflammatory ophthalmic agents, ophthalmic anti-infectives, ophthalmic anti-histamines, and decongestants are most commonly used ophthalmic drugs.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the pharma ophthalmic market.

Top Impacting Factors

  • Surge in cases of patient base suffering from chronic eye diseases, increase in geriatric population, rise in demand for minimally invasive procedure, and availability of advanced treatment procedures such as ophthalmic medication are the key factors that drive the growth of pharma ophthalmic market.
  • In addition, the effectiveness and advantages related to the ophthalmic medication, easy to apply the medication, and developing technologies such as eye drop suspensions & increased potency of ophthalmic drugs are some factors boost the market growth for pharma ophthalmic market.
  • However, side effects related to ophthalmic drugs hinder the market growth.
  • Contrarily, suitable compatibility of ophthalmic drugs in all ages and support from government for regulatory approvals are expected to offer lucrative opportunities for the expansion of the market. .

Key Market Trend

New Development and Product Launches to Flourish the Market

In January 2020, Horizon Therapeutics' Tepezza  (teprotumumab-trbw) infusion was approved by the FDA for the treatment of Thyroid Eye Disease (TED). TED can bring about vision misfortune and is related with a few other incapacitating side effects.  Tepezza infusion is used as a human monoclonal counter acting agent and inhibitor of factor receptor.

In 2019, Sun Pharma launched Cequa  cyclosporine ophthalmic solution. This formulation is in the form of eye drops and has the ability to increase amount of tears, which is used in treatment of chronic dry eyes.

Surge in Usage of Ophthalmic Products in Eye Disease Treatment

Increase in cases of eye diseases and disorders and rise in demand for minimally invasive procedure drive the growth of pharma ophthalmic market. As per the data of World Health Organization (WHO) in 2018, Glaucoma is the second leading reason for causing the blindness. In India, around 12 million people are affected by glaucoma. In addition, surge in healthcare expenditure, increase in availability of skilled professionals, collaborations & partnerships between key players to facilitate drug development, increase in R&D to improve quality of ophthalmic drugs, and launches of novel developed ophthalmic products such as eye drop suspension in market are some factors that augment the market growth of the pharma ophthalmic market.

Key Benefits of the Report

  • This study presents the analytical depiction of pharma ophthalmic market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years

Questions Answered in the Pharma Ophthalmic Market Report                 

  • Which are the leading players active in the pharma ophthalmic market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "pharma ophthalmic"?
  • What is "pharma ophthalmic" market prediction in the future?
  • Who are the leading global players in the "pharma ophthalmic" market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "pharma ophthalmic" market report?

Pharma Ophthalmic Market Report Highlights

Aspects Details
By Product Type
  • Retinal Disorder Drugs
  • Allergic
By Application
  • Glaucoma
  • Dry Eye Syndrome
  • Retinal Diseases
  • Other Ophthalmic Indications
By Distribution Channel
  • Hospital Pharmacy
  • Drugs Store  
  • Retail Pharmacist
  • Online Pharmacies
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Alcon inc., Sun Pharmaceutical Industries Ltd., Roche, Valeant, Bausch and Lomb Incorporated, Regeneron, Teva Pharmaceutical Industries ltd, Allergan, Pfizer inc., Novartis
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Pharma Ophthalmic Market

Start reading.
This Report and over 53,623+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers